GI Cancers Flashcards

(49 cards)

1
Q

define cancer

A

term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define primary cancer

A

Arising directly from the cells in an organ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define secondary/metastatic cancer

A

Spread from another organ, directly or by other means (blood or lymph)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hallmarks of cancer

A
resisting cell death
inducing angiogenesis
enabling replicative immortality
activating invasion and metastasis
evading growth suppressors
sustaining proliferative signalling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what four things underlie the hallmarks of cancer?

A

enabling characteristics: genome instability and mutation, tumor-promoting inflammation
emerging hallmarks: deregulating cellular energetics, avoiding immune destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cancer of squamous epithelium is called?

A

squamous cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cancer of glandular epithelium is called?

A

adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cancer of enteroendocrine cells is called?

A

neuroendocrine tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cancer of interstitial cells of Cajal is called?

A

gastrointestinal stromal tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

cancer of smooth muscle is called?

A

leiomyoma/leiomyosarcomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cancer of adipose tissue is called?

A

liposarcomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what diseases are suitable for screening? Wilson & Jungner criteria

A

important health problem
should be accepted treatment
available facilities for diagnosis and treatment
recognizable latent / early symptomatic stage
suitable test/exam
test should be acceptable to population
development of disease should be adequately understood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

list GI cancers that are screened for

A

colorectal
oesophageal
pancreatic + gastric
hepatocellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

screening for colorectal cancer

A

Offered to healthy individuals:
Faecal immunochemical test (FIT) - detects haemoglobin in faeces, every 2 years for everyone aged 60-74
One-off sigmoidoscopy for everyone aged >55 to remove polyps (reducing future risk of cancer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

screening for oesophageal cancer

A

Regular endoscopy to patients with:
Barrett’s oesophagus
Low- or high-grade dysplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

screening for hepatocellular cancer

A

Regular ultrasound & AFP for high-risk individuals with cirrhosis
Viral hepatitis
Alcoholic hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

patient’s cancer journey

A

signs and symptoms > diagnosis > staging > surgically removed?/systemic therapy (chemo)/radiotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

GI cancer MDT is made up of?

A
pathologist
cancer nurse specialist
surgeon
radiologist
palliative care
gastroenterologist
oncologist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

role of pathologist in GI cancer MDT

A

confirms cancer diagnosis using biopsy samples
provides histologic typing
provides molecular typing
provides tumour grade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

role of radiologist in GI cancer MDT

A

reviews scans
provides radiological tumour stage
provides restaging after treatment
interventional radiology

21
Q

role of surgeon in GI cancer MDT

A

decides whether surgery is appropriate

performs operation & cares for patient in perioperative period

22
Q

role of gastroenterologist in GI cancer MDT

A

endoscopy - diagnostic and therapeutic

stents and biopsies

23
Q

role of oncologist in GI cancer MDT

A

Decides on whether chemotherapy, radiotherapy or other systemic therapy is appropriate
Coordinates the overall treatment plan
Should chemotherapy come before surgery (neoadjuvant) or after (adjuvant)?

24
Q

purpose of MDT in cancer care

A

MDT decides whether plan should be for radical (curative) or palliative therapy or palliative care

25
what is the major driver of gastric adenocarcinoma?
chronic gastritis
26
causes of gastric adenocarcinoma
``` H.pylori infection pernicious anaemia partial gastrectomy epstein-barr virus infection heritable diffuse type gastric cancer ```
27
how does H.pylori infection lead to gastric cancer?
chronic acid overproduction
28
how does pernicious anaemia lead to gastric cancer?
autoantibodies against parts & products of parietal cells
29
how does partial gastrectomy lead to gastric cancer?
leading to bile reflux
30
what mutations in heritable diffuse type gastric cancer?
E-cadherin mutations
31
pathogenesis of gastric cancer
chronic gastritis > intestinal metaplasia > dysplasia > malignancy
32
what is the commonest symptom of GI cancer?
dyspepsia
33
red flag symptoms for GI cancers
``` anaemia loss of weight/appetite abdominal mass on examination recent onset of progressive symptoms melaena or haematemesis swallowing difficulty 55 years of age or above ```
34
diagnosis of GI cancer
similar to oesophageal cancer: endoscopy + biopsy
35
staging of GI cancer
CT of the chest, abdomen & pelvis will provide information on distant lesions PET-CT Diagnostic laparoscopy - peritoneal & liver metastases disease prior to full operation Endoscopic ultrasound - will give most detail about local invasion & node involvement
36
treatment options for gastric cancer
oesophago-gastrectomy total gastrectomy subtotal gastrectomy neoadjuvant/adjuvant chemotherapy
37
neuroendocrine tumours arise from?
Arise from the gastroenteropancreatic (GEP) tract (or bronchopulmonary system)
38
neuroendocrine tumours are associated with _________ in 25% and are __________ in 75%
genetic syndrome | sporadic
39
presentation of neuroendocrine tumours
most are asymptomatic and incidental abnormal hormonal secretion carcinoid syndrome
40
carcinoid syndrome
``` Vasodilatation Bronchoconstriction ^ intestinal motility Endocardial fibrosis (PR & TR) ```
41
clinical features of insulinoma
hypoglycaemia | Whipple's triad
42
clinical features of glucagonoma
diabetes mellitus | necrolytic migratory erythema
43
clinical features of gastrinoma
Zollingere-Ellison
44
clinical features of VIPoma
Verner-Morrison syndrome | watery diarrhoea
45
clinical features of somatostatinoma
gallstones diabetes mellitus steatorrhoea
46
diagnosis of neuroendocrine tumours - biochemical assessment
Chromogranin A is a secretory product of NETs Other gut hormones: insulin, gastrin, somatostatin, PPY Measured in fasting state Other screening: Calcium, PTH, prolactin, GH 24 hr urinary 5-HIAA (serotonin metabolite)
47
diagnosis of neuroendocrine tumours - imaging
``` Cross-sectional imaging (CT and/or MRI) Bowel imaging (endoscopy, barium follow through, capsule endoscopy) Endoscopic ultrasound Somatostatin receptor scintigraphy 68Ga-DOTATATE PET/CT most sensitive ```
48
why is tumour grade useful?
provides valuable prognostic information | influences management
49
treatment modalities for NETs
curative resection cytoreductive resection liver transplantation